Results 31 to 40 of about 29,046 (192)

Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.

open access: yesPLoS ONE, 2023
IntroductionLow Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects.ObjectivesThe ...
Giaele Moretti   +5 more
doaj   +1 more source

Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia. [PDF]

open access: yes, 2014
PURPOSE OF REVIEW: To review the recent developments in understanding the pathophysiology of heparin-induced thrombocytopenia (HIT) and in applying this knowledge to the treatment of patients with suspected and proven HIT.
McKenzie, Steven E., Sachais, Bruce S
core   +1 more source

Fondaparinux versus Enoxaparina no Tratamento de Pacientes Obesos com Síndrome Coronariana Aguda [PDF]

open access: yesArquivos Brasileiros de Cardiologia
Resumo Fundamento: O fondaparinux é um anticoagulante eficaz e seguro usado no tratamento de síndromes coronarianas agudas (SCAs). No entanto, devido à baixa representatividade de indivíduos obesos em ensaios clínicos, os efeitos de se aplicar os ...
Beatriz Rocha Darzé   +6 more
doaj   +1 more source

The Fondaparinux Paradox: Fondaparinux-Related Heparin-Induced Thrombocytopenia

open access: yesIndian Journal of Critical Care Medicine, 2018
Fondaparinux, a pentasaccharide administered for heparin-induced thrombocytopenia (HIT), can lead to the occurrence of thrombocytopenia. This patient underwent aortic stent graft placement for Salmonella paratyphi A-infected abdominal aortic aneurysm.
Vadi, Sonali, Peshattiwar, Vishal
openaire   +2 more sources

Retrospective Evaluation of Venous Thromboembolism Prophylaxis in the Adult Cancer Population [PDF]

open access: yes, 2009
Study objectives. Hospitalized cancer patients are at an increased risk for venous thromboembolism (VTE) and it is recommended they receive pharmacologic prophylaxis unless otherwise contraindicated.
Liu, Chin Y., Reeves, David J.
core   +2 more sources

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol

open access: yesBMC Pharmacology and Toxicology, 2023
Plain Language Summary New Fondaparinux Protocol to Reduce the Risk of Blood Thickening and Blood Clots Formation in Adults with Kidney Disease and Heparin-induced Thrombocytopenia (drop in platelets after the use of heparin): A Test Study.
Dania Ghaziri   +5 more
doaj   +1 more source

Choosing Between Enoxaparin and Fondaparinux for the Prevention of Thromboembolism: A Meta-Analysis of Randomized Trials

open access: yesEgyptian Journal of Critical Care Medicine, 2022
Background Venous thromboembolism (VTE), are few of the most serious complications in ICU. There are Pharmacological and mechanical prophylaxis methods are used to reduce the risk of thromboembolism and the most efficient is the pharmacological methods ...
Enas W. Mahdy   +3 more
doaj   +1 more source

Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study

open access: yesMedicina, 2022
Background and objectives: Cementless total hip arthroplasty is a common surgical procedure and perioperative thromboprophylaxis is used to prevent deep vein thrombosis or pulmonary embolism.
Dragos Apostu   +11 more
doaj   +1 more source

Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists clinical guideline [PDF]

open access: yes, 2018
Lumbar puncture (LP) is an important and frequently performed invasive procedure for the diagnosis and management of neurological conditions. There is little in the neurological literature on the topic of periprocedural management of antithrombotics in ...
Chhetri, Suresh   +3 more
core   +1 more source

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa

open access: yesClinical and Applied Thrombosis/Hemostasis, 2020
Andexanet alfa is a recombinant factor Xa decoy protein, designed to reverse bleeding associated with oral anti-Xa agents. Andexanet alfa is also reported to neutralize the effects of heparin-related drugs.
Fakiha Siddiqui BDS   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy